Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.32 USD | +0.69% | -4.35% | +21.84% |
May. 13 | Piper Sandler Adjusts Price Target on Myriad Genetics to $28 From $23, Maintains Neutral Rating | MT |
May. 08 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
Financials (USD)
Sales 2024 * | 831M | Sales 2025 * | 896M | Capitalization | 2.11B |
---|---|---|---|---|---|
Net income 2024 * | -92M | Net income 2025 * | -64M | EV / Sales 2024 * | 2.43 x |
Net cash position 2024 * | 93.93M | Net cash position 2025 * | 116M | EV / Sales 2025 * | 2.22 x |
P/E ratio 2024 * |
-24.9
x | P/E ratio 2025 * |
-33.3
x | Employees | 2,700 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.91% |
Latest transcript on Myriad Genetics, Inc.
1 day | +0.69% | ||
1 week | -4.35% | ||
Current month | +19.16% | ||
1 month | +28.27% | ||
3 months | +7.91% | ||
6 months | +24.84% | ||
Current year | +21.84% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Diaz
CEO | Chief Executive Officer | 61 | 20-08-12 |
Scott Leffler
DFI | Director of Finance/CFO | 49 | Jan. 28 |
Dale Muzzey
CTO | Chief Tech/Sci/R&D Officer | 44 | 14-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
S. Phanstiel
CHM | Chairman | 65 | 09-09-15 |
Paul Bisaro
BRD | Director/Board Member | 63 | 22-10-30 |
Dan Spiegelman
BRD | Director/Board Member | 65 | 20-05-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.24% | 14 M€ | -5.21% | ||
0.26% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 23.32 | +0.69% | 417,034 |
24-05-24 | 23.16 | -0.47% | 365,955 |
24-05-23 | 23.27 | -3.00% | 583,546 |
24-05-22 | 23.99 | -1.60% | 680,508 |
24-05-21 | 24.38 | -2.52% | 415,167 |
Delayed Quote Nasdaq, May 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.84% | 2.11B | |
-6.56% | 12.1B | |
-4.07% | 8.14B | |
+6.26% | 5.72B | |
+28.13% | 5.51B | |
-59.44% | 2.72B | |
+8.04% | 2.59B | |
-7.60% | 2.34B | |
-8.15% | 1.79B | |
+0.97% | 1.56B |
- Stock Market
- Equities
- MYGN Stock